Latest NAV & returns of NIPPON INDIA PRIVATE LTD.

Nippon India Pharma Fund Direct Plan Payout Inc Dist cum Cap Wdrl

Add To Compare

previously known as Nippon India Pharma Dir DP until

NAV on June 18, 2024
Category Equity:
Sector - Healthcare
Investment StyleBox
Large Growth
Total Assets 7,161 cr
Turnover Ratio 18.67%
Expense Ratio 0.92%
Exit Load 1.00%if redeemed within
1 Months
0.00%if redeemed after 1 Months
Returns
  • 1M: 3.93%
  • 1Y: 48.05%
  • 3M: 6.90%
  • 3Y: 17.60%
  • 6M: 18.94%
  • 5Y: 29.75%
Min Investment 5,000
ADDITIONAL INFO
Fund Manager Sailesh Raj Bhan (Since about 19 years) Kinjal Desai (Since about 6 years)
ISIN INF204K01I35
Fund Family Nippon India
P/E Ratio 37.92
P/B Ratio 6.00
Launch Date January 01, 2013
Benchmark BSE Healthcare TR INR
ASSET ALLOCATION
EQUITY DISTRIBUTION
RISK MEASURES (3 yrs)
vs BSE Healthcare TR INR

Alpha 3.09
Beta 0.91
R-Squared 94.99
Info Ratio 0.83
Tracking Err 3.43
Sortino 1.252
Sharpe 0.741
Std Dev 14.189
Risk -
SECTOR WEIGHTINGS (%)
Financial 0.0%
Industrial 0.0%
Technology 0.0%
Basic Materials 0.0%
Consumer Cyclical 0.0%
Utilities Services 0.0%
Healthcare Services 100.00%
Energy Services 0.00%
Communication Services 0.00%
Consumer Defensive 0.00%
Real Estate 0.00%
INVESTMENT OBJECTIVE

The primary investment objective of the scheme is to seek to generate consistent returns by investing in equity and equity related or fixed income securities of Pharma and other associated companies.

This fund may declare and pay out a dividend to you on a periodic basis, but only when it has the profits to do so.

View Factsheet

-
Best Sector Healthcare Funds
NAME LATEST
NAV
RETURNS
1y    
FUND
ASSETS
Expense
RATIO
RISK
407.312 48.25% 2,613 cr 0.95% -


Other plans of Nippon India Pharma


Other Equity funds by Nippon India